This recommendation takes into consideration several cautionary points: the tumorigenicity of 20q11.21 reported in other systems including cancers [8]; the risk of 20q11.21 being a baseline susceptibility factor for following oncogenic mutations [8]; and finally BCL-XL effect on the senescence of RPE over time [40]. Here, BCL2L1 is linked to cancer.